Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2-Reference-Cited by-同舟云学术

Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2

Published:2022-03 Issue:14 Volume:40 Page:2129-2133
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kageyama Takahiro,Tanaka Shigeru,Etori Keishi,Hattori Koto,Miyachi Kazusa,Kasuya Tadamichi,Iwamoto Taro,Ikeda Kei,Igari Hidetoshi,Yokote Koutaro,Nakajima Hiroshi

Funder

Chiba University

JST

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting;Dagan;N Engl J Med,2021

2. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

3. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7;Wang;Nature,2021

4. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants;Liu;Nature,2021

5. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera;Miyakawa;J Mol Cell Biol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody responses after BNT162b2 vaccination in Japanese geriatric intermediate care facilities;Vaccine: X;2023-12

2. Incidence of COVID-19 Vaccination-Related Uveitis and Effects of Booster Dose in a Tertiary Uveitis Referral Center;Frontiers in Medicine;2022-06-22